Literature DB >> 21825179

Bacterial dispersal associated with speech in the setting of intravitreous injections.

Joanne C Wen1, Colin A McCannel, A Brian Mochon, Omai B Garner.   

Abstract

OBJECTIVE: To investigate the amount of bacterial dispersal associated with speech in a simulated intravitreous injection.
METHODS: Fifteen volunteers were recruited. Each volunteer was positioned over an open blood agar plate and did the following: read a 5-minute script with a face mask, read a 5-minute script without a face mask, read a 5-minute script with the face turned away from the plate without a face mask, and stood in silence for 5 minutes. Each volunteer then read a 5-minute script while reclined in a standard ophthalmic examination chair with an open blood agar plate secured to the forehead to simulate bacterial dispersal associated with a talking patient. Total numbers of colony-forming bacteria per plate were counted, and the bacteria were identified.
RESULTS: Significantly less bacterial growth occurred in the face mask and silence conditions compared with the no face mask condition (both P < .001). Bacterial growth was significantly greater in the reclined condition compared with the room control (P = .02). Oral streptococcal species represented 66.7% to 82.6% of bacterial colonies in the no face mask, face turned, and reclined conditions.
CONCLUSIONS: During simulated intravitreous injection, wearing a face mask or remaining silent significantly decreases culture plate contamination from talking. Talking from above and talking in the reclined position were associated with a significant increase in culture plate contamination. Physicians performing intravitreous injections should be aware of these patterns of bacterial contamination, should consider either wearing a face mask or minimizing speech, and should encourage patients to minimize speech during the procedure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21825179     DOI: 10.1001/archophthalmol.2011.227

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  32 in total

1.  Real-World Trends in Intravitreal Injection Practices among American Retina Specialists.

Authors:  Rahul Chaturvedi; Kendall W Wannamaker; Paul J Riviere; Arshad M Khanani; Charles C Wykoff; Daniel L Chao
Journal:  Ophthalmol Retina       Date:  2019-04-04

Review 2.  Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery.

Authors:  Rachel R Hartman; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2017-12-05       Impact factor: 2.671

3.  The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection.

Authors:  Philip Storey; Michael Dollin; Nadim Rayess; John Pitcher; Sahitya Reddy; James Vander; Jason Hsu; Sunir Garg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-05       Impact factor: 3.117

4.  Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask.

Authors:  Hiroyuki Shimada; Takayuki Hattori; Ryusaburo Mori; Hiroyuki Nakashizuka; Kyoko Fujita; Mitsuko Yuzawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-07       Impact factor: 3.117

5.  Culture-Proven Endophthalmitis After Intravitreal Injection: A 10-Year Analysis.

Authors:  Joseph M Simonett; Austin Igelman; Stanford C Taylor; J Peter Campbell; Thomas S Hwang; Phoebe Lin; Andreas K Lauer; Christina J Flaxel
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2019-01-01       Impact factor: 1.300

6.  Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results.

Authors:  Roger A Goldberg; Harry W Flynn; Darlene Miller; Serafin Gonzalez; Ryan F Isom
Journal:  Ophthalmology       Date:  2013-02-28       Impact factor: 12.079

7.  Study of the Acute Effects of Povidone-Iodine on Conjunctival Bacterial Flora.

Authors:  Jeff H Pettey; Mark D Mifflin; Randall J Olson
Journal:  J Ocul Pharmacol Ther       Date:  2015-08-19       Impact factor: 2.671

8.  Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

Authors:  Stephen G Schwartz; Harry W Flynn
Journal:  Curr Ophthalmol Rep       Date:  2014-03-01

Review 9.  Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature.

Authors:  K Ghasemi Falavarjani; Q D Nguyen
Journal:  Eye (Lond)       Date:  2013-05-31       Impact factor: 3.775

Review 10.  Ocular Infection: Endophthalmitis.

Authors:  Stephen G Schwartz; Harry W Flynn; Taraprasad Das; William F Mieler
Journal:  Dev Ophthalmol       Date:  2015-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.